About Hikma Pharmaceuticals PLC (HIK)
Hikma Pharmaceuticals PLC is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector.
HIK trades on the London Stock Exchange and is classified as a large-cap stock .
Key Statistics
- Current Price
- £1,731.00
- Market Cap
- £3.58B
- 52-Week High
- £1,845.00
- 52-Week Low
- £1,187.00
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
£1,000 Invested in Hikma Pharmaceuticals PLC (HIK)
How much would £1,000 invested in HIK be worth today?
What would £1,000 invested in HIK 1 year ago be worth today?
A £1,000 investment in Hikma Pharmaceuticals PLC (HIK) in 2025 would be worth £951 as of November 2026, representing a -4.9% total return.
What would £1,000 invested in HIK 3 years ago be worth today?
A £1,000 investment in Hikma Pharmaceuticals PLC (HIK) in 2023 would be worth £962 as of November 2026, representing a -3.8% total return.
What would £1,000 invested in HIK 5 years ago be worth today?
A £1,000 investment in Hikma Pharmaceuticals PLC (HIK) in 2021 would be worth £704 as of November 2026, representing a -29.6% total return.
What would £1,000 invested in HIK 10 years ago be worth today?
A £1,000 investment in Hikma Pharmaceuticals PLC (HIK) in 2016 would be worth £984 as of November 2026, representing a -1.6% total return.
What would £1,000 invested in HIK at IPO be worth today?
A £1,000 investment in Hikma Pharmaceuticals PLC (HIK) at IPO would be worth £6,107 as of November 2026, representing a +510.7% total return.
Monthly Returns Heatmap
Over the past 20+ years (251 months), Hikma Pharmaceuticals PLC (HIK) has averaged a monthly return of +1.08% with a median return of +0.35%. The stock had 138 positive months (55%) and 112 negative months (45%). The best month in HIK's history was March 2018 with a +40.3% return, while the worst was August 2022 at -24.1%. Historically, December tends to be the strongest month (averaging +4.6%), and November the weakest (-2.7%).
HIK's longest winning streak was 8 consecutive months of gains, while its longest losing streak was 9 consecutive months of losses. The best full year was 2014 with a cumulative return of +54.3%, and the worst was 2017 at -45.4%.
Annual Returns
Over 21 years of trading history, Hikma Pharmaceuticals PLC (HIK) has delivered an average annual return of +11.77% with a median return of +15.30%. The compound annual growth rate (CAGR) is +7.18%. The stock posted gains in 13 years (62%) and losses in 8 years (38%).
HIK's best year was 2014 with a +64.80% gain, while the worst was 2017 at -40.08%. The longest streak of consecutive positive years was 4, and the longest losing streak was 2 years. HIK achieved double-digit gains (10%+) in 13 years. It suffered double-digit losses in 7 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +11.73% | £1,549.30 | £1,731.00 |
| 2025 | -22.20% | £1,991.35 | £1,549.30 |
| 2024 | +11.44% | £1,786.97 | £1,991.35 |
| 2023 | +15.30% | £1,549.83 | £1,786.97 |
| 2022 | -30.04% | £2,215.38 | £1,549.83 |
| 2021 | -11.86% | £2,513.49 | £2,215.38 |
| 2020 | +26.49% | £1,987.06 | £2,513.49 |
| 2019 | +16.05% | £1,712.30 | £1,987.06 |
| 2018 | +51.35% | £1,131.35 | £1,712.30 |
| 2017 | -40.08% | £1,888.23 | £1,131.35 |
| 2016 | -17.72% | £2,294.95 | £1,888.23 |
| 2015 | +16.28% | £1,973.62 | £2,294.95 |
| 2014 | +64.80% | £1,197.61 | £1,973.62 |
| 2013 | +57.84% | £758.75 | £1,197.61 |
| 2012 | +22.76% | £618.10 | £758.75 |
| 2011 | -23.59% | £808.91 | £618.10 |
| 2010 | +59.14% | £508.31 | £808.91 |
| 2009 | +45.73% | £348.80 | £508.31 |
| 2008 | -26.04% | £471.58 | £348.80 |
| 2007 | +29.58% | £363.93 | £471.58 |
| 2006 | -9.75% | £403.26 | £363.93 |
Frequently Asked Questions: HIK
What sector is HIK in? ▼
HIK operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has HIK performed historically? ▼
Over 21 years of trading history, HIK has posted gains in 13 years (62% of the time). The best year was 2014 with a +64.8% return. Past performance does not guarantee future results.
How can I invest in HIK? ▼
You can invest in HIK through any brokerage account that offers access to the London Stock Exchange. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold HIK.
Last updated: 11/1/2026